Predictors of pre-hospital delay in patients with ST-segment elevation myocardial infarction

Sílvia Ribeiro1, Antonio Gaspar, Sérgia Rocha

  • 1Serviço de Cardiologia, Hospital de S. Marco, Braga, Portugal. silviamartinsribeiro@gmail.com

Insights

Longer pre-hospital delays in ST-elevation myocardial infarction (STEMI) patients are linked to female gender, diabetes, hypertension, and nighttime symptom onset. This delay reduces reperfusion therapy rates and worsens outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Early reperfusion therapy is critical for successful ST-elevation myocardial infarction (STEMI) treatment.
  • Prehospital delay significantly impacts STEMI patient outcomes.
  • Understanding factors contributing to delayed care is essential for improving treatment strategies.

Purpose of the Study:

  • To characterize STEMI patients experiencing prolonged prehospital delays.
  • To identify predictors of extended prehospital delay.
  • To analyze the impact of prehospital delay on treatment choices and in-hospital prognosis.

Main Methods:

  • Retrospective cohort study of 797 STEMI patients (2002-2007).
  • Defined longer prehospital delay as >= 3 hours.
  • Analyzed demographic, clinical, and echocardiographic data to identify predictors and outcomes.

Main Results:

  • Patients with longer delays were older, more often female, diabetic, hypertensive, and had symptom onset at night.
  • Predictors of delay included female gender, diabetes, hypertension, and nighttime onset.
  • Longer delays correlated with reduced reperfusion therapy rates and lower left ventricular ejection fraction (LVEF).

Conclusions:

  • A significant proportion of STEMI patients face long prehospital delays.
  • Female patients, diabetics, hypertensives, and those with nighttime symptom onset are disproportionately affected.
  • Reducing prehospital delay is crucial to improve reperfusion rates, cardiac function, and potentially in-hospital mortality.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...